Skip to main content
Vivos Therapeutics, Inc. (VVOS)
NASDAQ: VVOS · IEX Real-Time Price · USD
2.290
+0.030 (1.33%)
At close: May 17, 2024, 4:00 PM
2.340
+0.050 (2.18%)
After-hours: May 17, 2024, 7:59 PM EDT

Vivos Therapeutics Revenue

Vivos Therapeutics had revenue of $13.36M in the twelve months ending March 31, 2024, down -17.70% year-over-year. Revenue in the quarter ending March 31, 2024 was $3.42M, a -11.36% decrease year-over-year. In the year 2023, Vivos Therapeutics had annual revenue of $13.80M, a decrease of -13.87%.

Revenue (ttm)
$13.36M
Revenue Growth
-17.70%
P/S Ratio
0.55
Revenue / Employee
$117,219
Employees
114
Market Cap
7.33M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202313.80M-2.22M-13.87%
Dec 31, 202216.02M-861.00K-5.10%
Dec 31, 202116.89M3.82M29.23%
Dec 31, 202013.07M1.67M14.68%
Dec 31, 201911.39M7.60M200.43%
Dec 31, 20183.79M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

VVOS News

More News